Search
forLearn
5 / 801 resultslearn Fexofenadine
learn fusidic acid
learn PP405
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
learn phenoxyethanol
Research
5 / 95 results
research Diagnostic approach to the pruritic cat
Finding the cause of a cat's itchiness requires a careful process and good communication with the owner.
research Feline Non-Flea Induced Hypersensitivity Dermatitis
Cats can get skin issues from things other than fleas, like insect bites, food, or allergens.
research Case 3
Effective flea control can resolve hair loss in cats.
research Abstracts
New treatments and diagnostic methods for various animal skin conditions showed promising results.
research Feline Dermatology
The document explains various skin conditions in cats and how to diagnose and treat them.
Community Join
5 / 1000+ resultscommunity RU58841 in powder form from Aliexpress. Is this safe to purchase?
A user is considering buying RU58841 powder from Aliexpress to mix with Minoxidil for hair loss treatment. Another user warns about the safety concerns of RU58841, especially from unreliable sources, and suggests trying finasteride, oral Minoxidil, and dutasteride first.
community NW4 -> NW 2.5 (1yr progress) RU 8.5-9% ED and topical Dut .1% + RU 5% 1.5x a week. (+ caffeine redensyl scalp treatment ED)
The conversation discusses hair regrowth progress from Norwood scale 4 to 2.5 over a year using daily 8.5-9% RU58841, topical Dutasteride 0.1%, RU58841 5% 1.5 times a week, and daily caffeine redensyl scalp treatment.
community Trial for TDM-105795 update from research office
The trial for TDM-105795 has been completed, and it was in phase 2A. The discussion seeks input on the next phases, 2B or 3, based on safety and efficacy.
community Pelage, PP405, is creating a database for potential new trial volunteers
PP405 is a new hair loss treatment targeting dormant hair follicles, with ongoing trials. Some users consider stopping finasteride and minoxidil to join trials, while others doubt its effectiveness.
community Follicum releases some data from previous phase 2a trial
Follicum discovered that their drug FOL-005 increased hair count by 12 hairs per cm2 in patients with less than 255 hairs per cm2 and is planning a phase 2b trial. They are currently fundraising for the trial, and the drug may also be effective for women.